Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First? D. Moreno-Ramírez, A. Fernández-Orland, L. Ferrándiz

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management S.J.E. Hwang, R. Anforth, G. Carlos, P. Fernandez-Peñas

Current State of Skin Cancer Prevention: A Systematic Review C. Alonso-Belmonte, T. Montero-Vilchez, S. Arias-Santiago, A. Buendía-Eisman